Related Experiment Video

Updated: Aug 14, 2026

A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology
16:46

A Novel Stretching Platform for Applications in Cell and Tissue Mechanobiology

Published on: June 3, 2014

Aortic compliance in young patients with heterozygous familial hypercholesterolaemia

E D Lehmann1, G F Watts, B Fatemi-Langroudi

  • 1Department of Endocrinology and Chemical Pathology, United Medical School, University of London, Guy's Hospital, U.K.

Clinical Science (London, England : 1979)
|December 1, 1992
PubMed

Insights

Young patients with familial hypercholesterolemia exhibit increased aortic compliance, linked to lipid levels. This finding suggests aortic compliance may predict atheroma risk in these individuals.

Area of Science:

  • Cardiovascular Research
  • Lipid Metabolism
  • Vascular Physiology

Background:

  • Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol.
  • Early detection and management of cardiovascular risk factors in FH are crucial for preventing premature atherosclerosis.
  • Understanding the relationship between lipid profiles and vascular function in young FH patients is essential for risk stratification.

Purpose of the Study:

  • To investigate aortic compliance in young patients with heterozygous familial hypercholesterolemia.
  • To determine the correlation between aortic compliance, plasma lipid and lipoprotein levels, and disease duration.
  • To explore the potential of aortic compliance as a non-invasive marker for assessing atheroma susceptibility in FH.

Main Methods:

  • Aortic compliance and plasma lipid/lipoprotein levels were measured in 20 young FH patients and 20 age/sex-matched controls.
  • Statistical analyses, including correlation and multivariate regression, were used to assess relationships between variables.
  • Aortic compliance was normalized for age and sex effects to evaluate lipid-related influences.

Main Results:

  • FH patients showed significantly higher plasma cholesterol, LDL-cholesterol, and triacylglycerol levels compared to controls.
  • Patients with FH had significantly more compliant aortas than controls, with inverse correlations between compliance and age/mean blood pressure.
  • Normalized aortic compliance correlated significantly with cholesterol, LDL-cholesterol, HDL-cholesterol, LDL/HDL ratio, and disease duration, with the LDL/HDL ratio and disease duration being the best predictors.

Conclusions:

  • Young FH patients exhibit altered aortic compliance, suggesting early vascular changes.
  • Aortic compliance is influenced by lipid profiles, particularly the LDL/HDL cholesterol ratio, and disease duration in FH.
  • Measuring aortic compliance may serve as a valuable, non-invasive research tool for assessing atheroma susceptibility in young FH patients.

More Related Videos

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes10:56

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes

Published on: September 15, 2018

Quantifying Inferior Vena Cava Compliance and Distensibility in an In Vivo Ovine Model Using 3D Angiography07:53

Quantifying Inferior Vena Cava Compliance and Distensibility in an In Vivo Ovine Model Using 3D Angiography

Published on: April 26, 2024

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...